Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.0MFederal grants as PI4 awards
0Patents grantedNone matched
155Papers8,471 citations
Federal awards and patents by year
AwardsPatents
4 awards · $3.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 20, 2018 | NIH | SBIR Phase II Developing a novel antifungal targeting Gwt1 for the treatment of invasive aspergillosis and rare mold infections | $726K | Amplyx Pharmaceuticals, Inc. |
| Jun 22, 2017 | NIH | SBIR Phase II Developing a Novel, Fungicidal Therapeutic to Treat Coccidioidomycosis | $732K | Amplyx Pharmaceuticals, Inc. |
| Jun 24, 2016 | NIH | SBIR Phase II Developing a New Therapeutic for the Treatment of Invasive Aspergillosis | $745K | Amplyx Pharmaceuticals, Inc. |
| Aug 25, 2015 | NIH | SBIR Phase II A Computer Modeling Approach | $749K | Amplyx Pharmaceuticals, Inc. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#631
Awards as PI#566
Patents#273
Companies
- Amplyx Pharmaceuticals, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.